General Information of the Compound
Compound ID
CP0434110
Compound Name
6-(4-bromophenylamino)-1,4,4-trimethyl-1H-benzo[d][1,3]oxazin-2(4H)-one
    Show/Hide
Structure
Formula
C17H17BrN2O2
Molecular Weight
361.239
Canonical SMILES
CN1C(=O)OC(C)(C)c2cc(Nc3ccc(Br)cc3)ccc12
    Show/Hide
InChI
InChI=1S/C17H17BrN2O2/c1-17(2)14-10-13(19-12-6-4-11(18)5-7-12)8-9-15(14)20(3)16(21)22-17/h4-10,19H,1-3H3
    Show/Hide
InChIKey
PVFYZNUIVXQJMV-UHFFFAOYSA-N
Physicochemical Property
logP
5.0142
Rotatable Bonds
2
Heavy Atom Count
22
Polar Areas
41.57
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11152632
SID: 16231421
ChEMBL ID
CHEMBL246885
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01172, Progesterone receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000078 T-47D Homo sapiens (Human)  1
1
IC50 = 54.4 nM
   TI
   LI
   LO
   TS